FDA Inspection 897378 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006295572

The FDA completed an inspection of Octapharma Plasma, Inc. on Sep 24, 2014 in Lynchburg, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 24, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lynchburg, VA (United States)

Citations

IDCFRDescription
4121 CFR 606.40(a)(1)Provide space for examination
442521 CFR 606.60(a)Equipment observed, standardized, calibrated
922521 CFR 606.171Biological product deviation report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.